NCT02284607View on ClinicalTrials.gov

A Study of High Dose MHAA4549A in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 3, 2014

Primary Completion Date

March 13, 2015

Study Completion Date

March 13, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

MHAA4549A

MHAA4549A single, intravenous dose administration, lower dose level

DRUG

MHAA4549A

MHAA4549A single, intravenous dose administration, higher dose level

DRUG

Placebo

Matching placebo to MHAA4549A administration

Trial Locations (1)

G1P 0A2

inVentiv Health Clinique, Québec

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY